On November 1, The Atlantic will host the fourth and final session in its 2012 Women of Washington event series, underwritten by ExxonMobil, featuring a conversation with Anne-Marie Slaughter, author of The Atlantic's July/August blockbuster cover story "Why Women Still Can't Have It All," in conversation with The Atlantic's Linda Douglass. To read the article and learn more about Anne-Marie, please visit TheAtlantic.com.
On the morning of September 18, The Atlantic hosted the third session in its 2012 Women of Washington event series, underwritten by ExxonMobil. Providing post-Conventions analysis and insights on the weeks of the campaign ahead, the event featured a conversation with Anita Dunn, former Obama White House Communications Director, and Sara Fagen, former Bush White House Political Director, led by The Atlantic's Steve Clemons.
As part of the second session in The Atlantic's 2012 Women of Washington Event Series, underwritten by ExxonMobil, on June 12 The Atlantic's Linda Douglass spoke with The Rockefeller Foundation's Judith Rodin on opportunities for investing in America's cities. From economic development in US urban areas to Judith's own work as a pioneering woman in academia and advocacy, the conversation will offer insights sure to inspire conversations across energy, infrastructure, and social platforms.
On Monday, May 14th, Caryl Stern, President and CEO of the UNICEF US Fund, joined The Atlantic’s Linda Douglass for a candid conversation on the most pressing humanitarian crises worldwide. The session shed light on Caryl’s work to alleviate global health disparities and address world hunger, particularly among women and children.
Featuring Graham Allison
and Jeffrey Goldberg
Graham Allison, Director of Harvard University's Belfer Center for Science and International Affairs, and author of Destined for War: Can America and China Escape Thucydides’s Trap?, will join The Atlantic’s Editor in Chief Jeffrey Goldberg to explore the US-China relationship and see how war in East Asia can be avoided.
The Next Drugs:
An Atlantic Policy Update on Biosimilars
The Atlantic will convene key stakeholders to discuss the state of and future for biosimilars.